More information: Sanna Toppila‐Salmi et al, Predictors of revision endoscopic sinus surgery in Finnish patients with chronic ...

In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...

Tezepelumab was linked to significantly reduced nasal polyp size and nasal congestion vs placebo in adults with severe CRSwNP.

A decision to proceed with nasal polyp surgery was recorded in just 0.5% of tezepelumab-treated patients compared to 22.1% in the placebo group (hazard ratio, 0.02). Systemic glucocorticoid use ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis. “This allows for early prediction of disease ...

The need for systemic corticosteroids fell by 88%, and the need for surgery fell by 98%. Nasal polyp and congestion scores fell, along with loss of smell and total symptom scores. SAN DIEGO ...

Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) significantly reduced nasal polyp severity, the need for subsequent surgery ...

3). Rigid rhinoscopes are preferred by some otolaryngologists, and are routinely used for endoscopic surgery. Flexible fiberoptic rhinoscopy may be used to demonstrate nasal polyps , septal spurs ...

In the polypoid form of the disease, mucosal protrusions, or polyps, block the nasal and ... If these treatments are insufficient, endoscopic sinus surgery can be considered.

In the polypoid form of the disease, mucosal protrusions, or polyps, block the nasal and ... If these treatments are insufficient, endoscopic sinus surgery can be considered.